跳至主要内容
临床试验/NL-OMON49354
NL-OMON49354已完成不适用

Registering the immune response to an influenza vaccination challenge in PTEN Hamartoma Tumour Syndrome - Immune response to flu vaccination in PHTS

Radboud Universitair Medisch Centrum0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Diagnosed with a pathogenic PTEN mutatution leading to PHTS (for PHTS group)
  • -18 years or older
  • -Mentally capable
  • -Must provide written informed consent
  • -is registered at the radboudumc

排除标准

  • -Known history of relevant medical disorder, which in the investigator's
  • judgment might have an impact on the findings of the study, or ppose additional
  • risk to the subject by participation in the study.
  • -Hypersensitivity to previous influenza vaccinations
  • -Must not be allergic to chicken eggwhite
  • -Immunocomprimised patients and those receiving concomitant immunosuppressive
  • -Bleeding disorders such as haemophilia and thrombocytopenia.
  • -Must not have received vaccinations with attenuated pathogens in the 4 weeks
  • leading up to the vaccination.
  • -Acute infection or recent ilness similar to to influenza.

研究者

相似试验